Association between a functional polymorphism in the monoamine oxidase A gene promoter and major depressive disorder

TG Schulze, DJ Müller, H Krauss… - American journal of …, 2000 - Wiley Online Library
Various polymorphisms of the X‐chromosomal monoamine oxidase A (MAO‐A) gene were
investigated for association with affective disorders. However, none of the studied variants …

Molecular genetic overlap in bipolar disorder, schizophrenia, and major depressive disorder

TG Schulze, N Akula, R Breuer, J Steele… - The World Journal of …, 2014 - Taylor & Francis
Objectives. Genome-wide association studies (GWAS) in complex phenotypes, including
psychiatric disorders, have yielded many replicated findings, yet individual markers account for …

Biological insights from 108 schizophrenia-associated genetic loci

…, AR Sanders, U Schall, CR Schubert, TG Schulze… - Nature, 2014 - nature.com
Schizophrenia is a highly heritable disorder. Genetic risk is conferred by a large number of
alleles, including common alleles of small effect that might be detected by genome-wide …

Identification of loci associated with schizophrenia by genome-wide association and follow-up

…, S Zammit, J Schumacher, EM Quinn, TG Schulze… - Nature …, 2008 - nature.com
We carried out a genome-wide association study of schizophrenia (479 cases, 2,937 controls)
and tested loci with P < 10 −5 in up to 16,726 additional subjects. Of 12 loci followed up, 3 …

Bipolar disorders

E Vieta, M Berk, TG Schulze, AF Carvalho… - Nature reviews Disease …, 2018 - nature.com
Bipolar disorders are chronic and recurrent disorders that affect> 1% of the global population.
Bipolar disorders are leading causes of disability in young people as they can lead to …

[PDF][PDF] Genome-wide association study identifies genetic variation in neurocan as a susceptibility factor for bipolar disorder

…, J Hauser, A Zimmer, M Lathrop, TG Schulze… - The American Journal of …, 2011 - cell.com
We conducted a genome-wide association study (GWAS) and a follow-up study of bipolar
disorder (BD), a common neuropsychiatric disorder. In the GWAS, we investigated 499,494 …

The International Consortium on Lithium Genetics (ConLiGen): an initiative by the NIMH and IGSLI to study the genetic basis of response to lithium treatment

TG Schulze, M Alda, M Adli, N Akula, R Ardau… - …, 2010 - karger.com
For more than half a decade, lithium has been successfully used to treat bipolar disorder.
Worldwide, it is considered the first-line mood stabilizer. Apart from its proven antimanic and …

Microduplications of 16p11. 2 are associated with schizophrenia

…, FJ McMahon, AK Malhotra, JB Potash, TG Schulze… - Nature …, 2009 - nature.com
Recurrent microdeletions and microduplications of a 600-kb genomic region of chromosome
16p11.2 have been implicated in childhood-onset developmental disorders 1 , 2 , 3 . We …

Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study

…, M Alda, M Rietschel, FJ McMahon, TG Schulze - The Lancet, 2016 - thelancet.com
Background Lithium is a first-line treatment in bipolar disorder, but individual response is
variable. Previous studies have suggested that lithium response is a heritable trait. However, …

What is familial about familial bipolar disorder?: Resemblance among relatives across a broad spectrum of phenotypic characteristics

TG Schulze, D Hedeker, P Zandi… - Archives of General …, 2006 - jamanetwork.com
Context Current diagnostic criteria for bipolar affective disorder define a phenotype that is
highly heritable, yet clinically variable. A more homogeneous definition might facilitate genetic …